📋 Tender Overview
Scope :
Nigerian drug manufacturing company, Fidson Healthcare Plc, has announced a partnership with Chinese firms to construct a $100 million pharmaceutical plant in Lagos. The collaboration, formalised through a memorandum of cooperation, includes Jiangsu Aidea Pharmaceutical Co., PharmaBlock Sciences Nanjing Inc., and the China-Africa Development Fund. The new facility is expected to be completed within 30 months.
Fidson’s venture aims to enhance Nigeria’s healthcare self-reliance, particularly in addressing HIV treatment needs. The country is home to approximately 2 million people living with HIV, according to the Joint United Nations Programme on HIV/AIDS.
Nigeria faces significant challenges in healthcare, with all anti-retroviral drugs currently being imported. This reliance, combined with economic pressures such as inflation, insecurity, and energy shortages, has contributed to a worsening shortage of essential medicines.
Partner :
PharmaBlock Sciences Nanjing Inc
Shangyu, Zhejiang, China National-level chemical industry park
pharmablock, China
Tel: +86-400 025 5188
Fax: +86-25 86918232
E-mail: sales_china@pharmablock.com
